-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
IGC Pharma, Inc. quarterly/annual Revenues history and growth rate from 2010 to 2023.
- IGC Pharma, Inc. Revenues for the quarter ending September 30, 2024 was $412K, a 41.6% increase year-over-year.
- IGC Pharma, Inc. Revenues for the twelve months ending September 30, 2024 was $1.18M, a 11.9% decline year-over-year.
- IGC Pharma, Inc. annual Revenues for 2023 was $1.35M, a 47.6% increase from 2022.
- IGC Pharma, Inc. annual Revenues for 2022 was $911K, a 129% increase from 2021.
- IGC Pharma, Inc. annual Revenues for 2021 was $397K, a 55.8% decline from 2020.